Anisse Marques Chami

Anisse Marques Chami

Auto-generated profile, based on publicly available information

Anisse Marques Chami

Postgraduate Program in Obstetrics and Gynecology Faculdade de Medicina Universidade Estadual Paulista "Júlio de Mesquita Filho" Botucatu SP Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
CCCamila Martins de Carvalho
Camila Martins de Carvalho
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
LSLuciana Maria Silva
Luciana Maria Silva
ACAnisse Marques Chami
Anisse Marques Chami
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
Objective The present study evaluated the profile of germline mutations present in patients who underwent genetic counseling for risk assessment for breast cancer (BC), ovarian cancer (OC), and endometrial cancer (EC) with a possible hereditary pattern. Methods Medical records of 382 patients who underwent genetic counseling after signing an informed consent form were analyzed. A total of 55.76% of patients (213/382) were symptomatic (personal history of cancer), and 44.24% (169/382) were asymptomatic (absence of the disease). The variables analyzed were age, sex, place of birth, personal or family history of BC, OC, EC, as well as other types of cancer associated with hereditary syndromes. The Human Genome Variation Society (HGVS) nomenclature guidelines were used to name the variants, and their biological significance was determined by comparing 11 databases. Results We identified 53 distinct mutations: 29 pathogenic variants, 13 variants of undetermined significance (VUS), and 11 benign. The most frequent mutations were BRCA1 c.470_471delCT, BRCA1 c.4675 + 1G > T, and BRCA2 c.2T> G. Furthermore, 21 variants appear to have been described for the first time in Brazil. In addition to BRCA1/2 mutations, variants in other genes related to hereditary syndromes that predispose to gynecological cancers were found. Conclusion This study allowed a deeper understanding of the main mutations identified in families in the state of Minas Gerais and demonstrates the need to assess the family history of non-gynecological cancer for risk assessment of BC, OC, and EC. Moreover, it is an effort that contributes to population studies to evaluate the cancer risk mutation profile in Brazil.

15 June 2023 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
ACAnisse Chami
Anisse Chami
TZThalía Rodrigues de Souza Zózimo
Thalía Rodrigues de Souza Zózimo
TAThamiris Matias Alves
Thamiris Matias Alves
CMCarolina Guimarães Ramos Matosinho
Carolina Guimarães Ramos Matosinho
CSCleydson Santos
Cleydson Santos
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga

1 August 2021 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
JCJESUS PAULA CARVALHO
JESUS PAULA CARVALHO
FCFilomena Marino Carvalho
Filomena Marino Carvalho
ACAnisse Marques Chami
Anisse Marques Chami
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
WPWalquíria Quida Salles Pereira Primo
Walquíria Quida Salles Pereira Primo
The National Specialty Commission for Gynecologic Oncology of the Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO) endorses to this document. The content production is based on scientific studies on a thematic proposal and the findings presented contribute to clinical practice. Article published online: 21 September 2021 © 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

9 June 2025 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
DFDaniele Carvalhais França
Daniele Carvalhais França
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
ACAnisse Marques Chami
Anisse Marques Chami
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
Objective: To describe the epidemiological data of women with breast cancer at a referral center in oncology in the northern region of Brazil. Methods: This is a retrospective cohort study. The study population consists of patients who were diagnosed with in situ or invasive BC (invasive carcinoma of no special type (ICNST) and invasive […] Abstract Objective: To describe the epidemiological data of women with breast cancer at a referral center in oncology in the northern region of Brazil. Methods: This is a retrospective cohort study. The study population consists of patients who were diagnosed with in situ or invasive BC (invasive carcinoma of no special type (ICNST) and invasive […]

10 February 2023 in Mário Penna Journal
Verified
Journal Article
Open access
ACAnisse Marques Chami
Anisse Marques Chami
TZThalía Rodrigues de Souza Zózimo
Thalía Rodrigues de Souza Zózimo
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
O câncer epitelial de ovário e o câncer de endométrio apresentam uma alta taxa de mortalidade entre mulheres de todas as idades. Tanto na avaliação diagnóstica quanto de risco para essas neoplasias malignas deve-se considerar a possibilidade de uma etiologia hereditária, a qual pode ser identificável através de testes genéticos. O câncer de ovário de origem epitelial é um dos cânceres com maior relação com a hereditariedade, até 25% dos casos apresentam mutações germinativas identificáveis. Síndromes e/ou genes de alto risco para o câncer ginecológico como a Síndrome de predisposição ao câncer de mama e ovários associadas aos genes BRCA1/2, síndrome de Lynch aos genes MMR, Síndrome de Cowden ao gene PTEN, devem ser reconhecidas e podem ter impacto relevante para guiar condutas cirúrgicas e oncológicas. Entretanto, a abordagem faz-se através do processo do aconselhamento genético que é um processo dinâmico e que pode ser decisivo na avaliação do paciente oncológico e familiares em risco para câncer.

17 December 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
ACAnisse Marques Chami
Anisse Marques Chami
TZThalia Rodrigues de Souza Zózimo
Thalia Rodrigues de Souza Zózimo
CMCarolina Guimarães Ramos Matosinho
Carolina Guimarães Ramos Matosinho
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
MCMaria Raquel Santos Carvalho
Maria Raquel Santos Carvalho
Letícia Conceição BragaLetícia Conceição Braga
Letícia Conceição Braga
Highlights ■ Family identified with recurrent colorectal cancer, suggestive of Lynch syndrome. ■ A new variant was detected, NM_000251.3(MSH2):c.1894_1898del (p.Ile633Lysfs*9). ■ The variant causes a frameshift mutation leading to a premature stop codon, suggesting pathogenicity. ■ Using bioinformatics tools, we investigated possible escape mechanisms, such as the presence of isoforms without the mutated exon. ■ Location of the variant suggests that it causes non-sense mediated decay, which is reinforced by immunohistochemistry findings showing absence of MSH2 protein expression. ■ Detailed